X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.83 | -12,035 | 881,275 | -1% | -$21,993 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.87 | -8,934 | 173,999 | -5% | -$16,721 | |||||
| DM | 2026-01-26 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale+OE | $3.00 | -17,756 | 173,999 | -9% | -$53,280 | |||||
2026-02-02 | ABSI | Absci Corp | McClain Sean | CEO | S - Sale | $2.99 | -26,761 | 8,334,567 | 0% | -$80,015 | ||||||
2026-02-02 | ABSI | Absci Corp | Jonasson Zachariah | CFO , CBO | S - Sale | $2.99 | -17,496 | 383,538 | -4% | -$52,313 | ||||||
| D | 2026-01-20 | AERG | Applied Energetics, Inc. | McCahon Stephen William | Chief Science Officer | S - Sale+OE | $1.80 | -10,000 | 12,772,861 | 0% | -$18,000 | |||||
| D | 2026-01-21 | AERG | Applied Energetics, Inc. | Quarles Gregory James | CEO Emeritus | S - Sale+OE | $1.87 | -6,600 | 0 | -100% | -$12,342 | |||||
| D | 2026-01-26 | AERG | Applied Energetics, Inc. | Donaghey Christopher Wayne | Pres, CEO, Principal AO | S - Sale+OE | $1.65 | -10,000 | 133,592 | -7% | -$16,500 | |||||
2026-01-28 | AIMD | Ainos, Inc. | Taiwan Carbon Nano Technology Corp | 10% | S - Sale | $2.17 | -46,000 | 989,925 | -4% | -$99,806 | ||||||
2026-01-20 | AIRG | Airgain Inc | Elbaz Michael | CFO | S - Sale | $4.00 | -4,587 | 133,106 | -3% | -$18,330 | ||||||
2026-01-20 | AIRG | Airgain Inc | Sadri Ali | CTO | S - Sale | $4.00 | -4,733 | 127,030 | -4% | -$18,914 | ||||||
2026-01-20 | AIRG | Airgain Inc | Suen Jacob | Pres, CEO | S - Sale | $4.00 | -15,993 | 293,635 | -5% | -$63,908 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, GC | S - Sale | $1.39 | -69,772 | 588,378 | -11% | -$96,983 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | S - Sale | $1.39 | -49,524 | 299,390 | -14% | -$68,838 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Grund Nicholas | Chief Commercial Officer | S - Sale | $1.39 | -84,829 | 561,750 | -13% | -$117,912 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | S - Sale | $1.39 | -341,305 | 3,457,722 | -9% | -$474,414 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO, Treasurer | S - Sale | $1.39 | -34,951 | 672,635 | -5% | -$48,582 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.39 | -67,658 | 948,432 | -7% | -$94,045 | ||||||
2026-01-21 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.56 | -26,269 | 616,866 | -4% | -$40,980 | ||||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale+OE | $1.77 | -35,700 | 581,166 | -6% | -$63,189 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, GC | S - Sale+OE | $1.76 | -22,900 | 564,948 | -4% | -$40,304 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale+OE | $1.76 | -24,001 | 1,252,795 | -2% | -$42,242 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S - Sale+OE | $1.73 | -7,549 | 210,172 | -3% | -$13,060 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO | S - Sale+OE | $1.80 | -95,269 | 8,099,058 | -1% | -$171,484 | |||||
| DM | 2026-02-17 | CDLX | Cardlytics, Inc. | Gupta Amit | CEO | S - Sale+OE | $0.91 | -97,208 | 659,644 | -13% | -$88,765 | |||||
| M | 2026-01-26 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.98 | -19,274 | 580,329 | -3% | -$96,045 | |||||
| M | 2026-01-29 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.23 | -24,770 | 555,559 | -4% | -$104,862 | |||||
2026-02-03 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.10 | -5,559 | 550,000 | -1% | -$22,792 | ||||||
| M | 2026-01-20 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.84 | -50,000 | 150,000 | -25% | -$42,000 | |||||
| M | 2026-02-10 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.61 | -50,000 | 0 | -100% | -$30,500 | |||||
| M | 2026-01-27 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.84 | -50,000 | 100,000 | -33% | -$42,000 | |||||
| M | 2026-02-03 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.58 | -50,000 | 50,000 | -50% | -$29,000 | |||||
| D | 2026-02-02 | DGXX | Digi Power X Inc. | Amar Alec | Pres | S - Sale+OE | $2.53 | -27,500 | 1,308,116 | -2% | -$69,575 | |||||
2026-02-17 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $3.96 | -6,249 | 1,426,805 | 0% | -$24,746 | ||||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Kelly John Alexander | CFO | S - Sale+OE | $4.03 | -15,213 | 106,448 | -13% | -$61,308 | |||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $4.03 | -10,200 | 118,115 | -8% | -$41,106 | |||||
| D | 2026-01-22 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $4.17 | -34,799 | 196,154 | -15% | -$145,112 | |||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $4.03 | -8,854 | 44,715 | -17% | -$35,682 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $3.84 | -4,925 | 56,457 | -8% | -$18,912 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Kelly John Alexander | CFO | S - Sale+OE | $3.84 | -8,149 | 125,883 | -6% | -$31,292 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $3.84 | -20,559 | 243,392 | -8% | -$78,947 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $3.84 | -4,925 | 129,857 | -4% | -$18,912 | |||||
2026-02-17 | EGHT | 8X8 Inc /De/ | Denny Laurence | GC | S - Sale | $2.55 | -5,000 | 376,771 | -1% | -$12,732 | ||||||
2026-02-04 | EGHT | 8X8 Inc /De/ | Middleton Hunter | Chief Product Officer | S - Sale | $2.50 | -85,044 | 652,943 | -12% | -$212,814 | ||||||
| M | 2026-02-06 | EU | Encore Energy Corp. | Sheriff William M | See Remarks | S - Sale | $2.76 | -24,000 | 2,216,931 | -1% | -$66,240 | |||||
2026-02-02 | EXFY | Expensify, Inc. | Barrett David Michael | CEO | S - Sale | $1.45 | -30,000 | 1,531,047 | -2% | -$43,500 | ||||||
2026-01-30 | FAT | Fat Brands, Inc | Hot Gfg LLC | 10% | S - Sale | $0.27 | -1,794,766 | 1,544,623 | -54% | -$485,843 | ||||||
| D | 2026-02-18 | GERN | Geron Corp | Robertson Michelle | EVP, CFO | S - Sale+OE | $1.94 | -9,855 | 17,645 | -36% | -$19,119 | |||||
| M | 2026-02-12 | ISPR | Ispire Technology Inc. | Pryzbyla Steven P. | CLO, Secretary | S - Sale | $3.29 | -9,000 | 390,664 | -2% | -$29,592 | |||||
| M | 2026-01-06 | IVFH | Innovative Food Holdings Inc | Bennett Robert William | Former CEO and Director | S - Sale | $0.33 | -2,114,440 | 377,571 | -85% | -$703,364 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Andersen Jill | GC, Secretary | S - Sale+OE | $1.56 | -67,710 | 182,236 | -27% | -$105,581 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Green Julie | CHRO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Duke William E. | CFO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Allen Robert D. III | Chief Scientific Officer | S - Sale+OE | $1.56 | -37,581 | 114,487 | -25% | -$58,600 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Lee Timothy Edward | Chief Commercial Officer | S - Sale+OE | $1.56 | -40,627 | 117,717 | -26% | -$63,350 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Inglis Andrew G | COB, CEO | S - Sale | $1.39 | -148,182 | 4,227,017 | -3% | -$205,241 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Marion Josh R. | SVP, GC | S - Sale | $1.38 | -22,940 | 194,125 | -11% | -$31,592 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Shah Nealesh D. | SVP, CFO | S - Sale | $1.39 | -79,124 | 1,705,167 | -4% | -$109,634 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Glass Ronald W. | VP, Chief Accounting Officer | S - Sale | $1.38 | -22,598 | 339,632 | -6% | -$31,125 | |||||
2026-02-17 | LAW | Cs Disco, Inc. | Antoon Melanie | EVP, Chief Customer Officer | S - Sale | $3.07 | -9,289 | 289,493 | -3% | -$28,517 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Crum Richard Francis | EVP, Chief Prod, Tech Officer | S - Sale | $3.07 | -6,508 | 355,363 | -2% | -$19,980 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Herckis Karen | EVP, CHRO | S - Sale | $3.07 | -8,171 | 201,851 | -4% | -$25,085 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Garcia Susan | GC, Chief Compliance Officer | S - Sale | $3.07 | -3,743 | 158,877 | -2% | -$11,491 | ||||||
| D | 2026-01-27 | LWLG | Lightwave Logic, Inc. | El-Ahmadi Siraj Nour | Dir | S - Sale+OE | $3.48 | -25,591 | 123,944 | -17% | -$89,057 | |||||
| M | 2026-01-23 | MDBH | Mdb Capital Holdings, LLC | James Jeremy William | CFO | S - Sale | $3.32 | -3,500 | 19,839 | -15% | -$11,621 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Bharucha David | Chief Medical Officer | S - Sale+OE | $2.25 | -70,252 | 113,181 | -38% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Nelson Jeffrey Edward | COO | S - Sale+OE | $2.25 | -70,252 | 49,848 | -58% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Muller Lorenz | Chief Commercial Officer | S - Sale+OE | $2.25 | -64,746 | 205,406 | -24% | -$145,851 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Hasija Amit | CFO, EVP of Corp. Development | S - Sale+OE | $2.25 | -70,252 | 99,848 | -41% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Oliveto Joseph | Pres, CEO | S - Sale+OE | $2.24 | -167,577 | 482,744 | -26% | -$375,315 | |||||
2026-02-02 | MOBX | Mobix Labs, Inc | Sansone Philip | CEO | S - Sale | $0.19 | -87,025 | 1,848,816 | -4% | -$16,361 | ||||||
2026-02-17 | MQ | Marqeta, Inc. | Cummings Martha | Dir | S - Sale | $4.00 | -2,853 | 38,969 | -7% | -$11,410 | ||||||
2026-02-17 | MQ | Marqeta, Inc. | Sumner Crystal | See Remarks | S - Sale | $4.00 | -5,056 | 311,948 | -2% | -$20,212 | ||||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | S - Sale | $3.56 | -6,165 | 82,770 | -7% | -$21,917 | ||||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Berns Paul L | See Remarks | S - Sale | $3.51 | -9,819 | 7,794,476 | 0% | -$34,459 | ||||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Pinto Joshua | Pres | S - Sale | $3.54 | -5,967 | 209,950 | -3% | -$21,093 | ||||||
2026-02-02 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Pres, CEO | S - Sale | $0.50 | -113,297 | 1,378,025 | -8% | -$57,034 | ||||||
| M | 2026-01-26 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
| M | 2026-01-26 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
2026-01-29 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
2026-01-29 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
| M | 2026-02-13 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.11 | -175,000 | 775,000 | -18% | -$369,330 | |||||
| M | 2026-02-13 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.11 | -175,000 | 775,000 | -18% | -$369,330 | |||||
| M | 2026-02-10 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.04 | -250,000 | 950,000 | -21% | -$509,167 | |||||
| M | 2026-02-10 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.04 | -250,000 | 950,000 | -21% | -$509,167 | |||||
2026-02-17 | NRDY | Nerdy Inc. | Swenson Christopher C. | GC | S - Sale | $0.97 | -32,641 | 2,022,742 | -2% | -$31,662 | ||||||
2026-02-17 | NRDY | Nerdy Inc. | Pello Jason H. | CFO | S - Sale | $0.97 | -49,814 | 2,646,235 | -2% | -$48,320 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.70 | -6,828 | 259,402 | -3% | -$11,608 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.70 | -6,990 | 383,623 | -2% | -$11,883 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.70 | -20,754 | 4,375,787 | 0% | -$35,282 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.71 | -9,673 | 392,700 | -2% | -$16,541 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.71 | -9,301 | 268,851 | -3% | -$15,905 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.71 | -30,843 | 4,403,277 | -1% | -$52,742 | |||||
2026-02-17 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.35 | -3,361 | 144,592 | -2% | -$11,259 | ||||||
2026-02-17 | OPEN | Opendoor Technologies Inc. | Schwartz Christina | CFO | S - Sale | $4.32 | -74,248 | 3,844,214 | -2% | -$320,633 | ||||||
2026-02-02 | OPHC | Optimumbank Holdings, Inc. | Terry Timothy | PEO | S - Sale | $4.73 | -39,304 | 0 | -100% | -$185,908 | ||||||
2026-02-17 | OPTU | Optimum Communications, Inc. | Olsen Michael | GC, CCRO | S - Sale | $1.60 | -250,000 | 1,496,277 | -14% | -$400,000 | ||||||
| M | 2026-02-17 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.59 | -50,167 | 219,092 | -19% | -$79,856 | |||||
| M | 2026-02-17 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.59 | -472,667 | 2,673,500 | -15% | -$752,390 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |